Introduction: Sjögren’s syndrome is the second most frequent autoimmune rheumatic disease and is characterized by exocrine gland involvement manifesting as sicca symptoms. The objective of this study was to estimate the degree of agreement b
Consistency between anticholinergic burden scales in patients with Sjögren’s syndrome
Audifarma |
| Tiempo de lectura: Min
- Tema: Farmacovigilancia
- Autores: Luis Fernando Valladales-Restrepo, Jorge Enrique Machado-Alba
- Idiomas: Inglés
- Palabras clave: Síndrome de Sjögren Pilocarpina Antagonistas colinérgicos Interacciones medicamentosas FarmacovigilanciaSjögren’s Syndrome Pilocarpine Cholinergic antagonists Drug interactions Pharmacovigilance
"Valladales-Restrepo LF, Machado-Alba JE. Consistency between anticholinergic burden scales in patients with Sjögren’s syndrome. Rev Colomb Reumatol. 2020;27(S2):50–57" Enlace: https://www.elsevier.es/es-revista-revista-colombiana-reumatologia-374-articulo-consistency-between-anticholinergic-burden-scales-S012181232030058X